19-48955955-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_138761.4(BAX):​c.233+122A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.887 in 1,288,394 control chromosomes in the GnomAD database, including 507,793 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.89 ( 59785 hom., cov: 30)
Exomes 𝑓: 0.89 ( 448008 hom. )

Consequence

BAX
NM_138761.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.99

Publications

8 publications found
Variant links:
Genes affected
BAX (HGNC:959): (BCL2 associated X, apoptosis regulator) The protein encoded by this gene belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. This protein forms a heterodimer with BCL2, and functions as an apoptotic activator. The association and the ratio of BAX to BCL2 also determines survival or death of a cell following an apoptotic stimulus. This protein is reported to interact with, and increase the opening of, the mitochondrial voltage-dependent anion channel (VDAC), which leads to the loss in membrane potential and the release of cytochrome c. The expression of this gene is regulated by the tumor suppressor P53 and has been shown to be involved in P53-mediated apoptosis. Multiple alternatively spliced transcript variants, which encode different isoforms, have been reported for this gene. [provided by RefSeq, Dec 2019]
BAX Gene-Disease associations (from GenCC):
  • leukemia, acute lymphocytic, susceptibility to, 1
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.929 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BAXNM_138761.4 linkc.233+122A>G intron_variant Intron 3 of 5 ENST00000345358.12 NP_620116.1 Q07812-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BAXENST00000345358.12 linkc.233+122A>G intron_variant Intron 3 of 5 1 NM_138761.4 ENSP00000263262.9 Q07812-1

Frequencies

GnomAD3 genomes
AF:
0.886
AC:
134683
AN:
151988
Hom.:
59739
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.888
Gnomad AMI
AF:
0.788
Gnomad AMR
AF:
0.840
Gnomad ASJ
AF:
0.914
Gnomad EAS
AF:
0.951
Gnomad SAS
AF:
0.949
Gnomad FIN
AF:
0.922
Gnomad MID
AF:
0.905
Gnomad NFE
AF:
0.881
Gnomad OTH
AF:
0.871
GnomAD4 exome
AF:
0.888
AC:
1008654
AN:
1136288
Hom.:
448008
Cov.:
15
AF XY:
0.890
AC XY:
495764
AN XY:
557332
show subpopulations
African (AFR)
AF:
0.891
AC:
22271
AN:
24990
American (AMR)
AF:
0.833
AC:
15495
AN:
18598
Ashkenazi Jewish (ASJ)
AF:
0.916
AC:
16031
AN:
17492
East Asian (EAS)
AF:
0.961
AC:
31709
AN:
33004
South Asian (SAS)
AF:
0.946
AC:
53397
AN:
56434
European-Finnish (FIN)
AF:
0.926
AC:
34451
AN:
37224
Middle Eastern (MID)
AF:
0.897
AC:
2932
AN:
3268
European-Non Finnish (NFE)
AF:
0.880
AC:
789303
AN:
896930
Other (OTH)
AF:
0.891
AC:
43065
AN:
48348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
5502
11003
16505
22006
27508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17364
34728
52092
69456
86820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.886
AC:
134787
AN:
152106
Hom.:
59785
Cov.:
30
AF XY:
0.888
AC XY:
66027
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.887
AC:
36815
AN:
41490
American (AMR)
AF:
0.840
AC:
12833
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.914
AC:
3171
AN:
3468
East Asian (EAS)
AF:
0.951
AC:
4902
AN:
5154
South Asian (SAS)
AF:
0.949
AC:
4567
AN:
4812
European-Finnish (FIN)
AF:
0.922
AC:
9777
AN:
10604
Middle Eastern (MID)
AF:
0.912
AC:
268
AN:
294
European-Non Finnish (NFE)
AF:
0.881
AC:
59894
AN:
67990
Other (OTH)
AF:
0.872
AC:
1841
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
805
1609
2414
3218
4023
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
906
1812
2718
3624
4530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.885
Hom.:
22039
Bravo
AF:
0.878
Asia WGS
AF:
0.915
AC:
3182
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.32
DANN
Benign
0.54
PhyloP100
-3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3817074; hg19: chr19-49459212; API